| 物质名称 | CABOTEGRAVIR |
|---|---|
| 异名/同义词 | (3S,11AR)-N-((2,4-DIFLUOROPHENYL)METHYL)-6-HYDROXY-3-METHYL-5,7-DIOXO-2,3,5,7,11,11A-HEXAHYDROOXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE APRETUDE CABENUVA COMPONENT CABOTEGRAVIR CABOTEGRAVIR CABOTEGRAVIR [INN] CABOTEGRAVIR [JAN] CABOTEGRAVIR [ORANGE BOOK] CABOTEGRAVIR [USAN] CABOTEGRAVIR [WHO-DD] GSK1265744 GSK-1265744 GSK1265744A GSK-1265744A GSK744 OXAZOLO(3,2-A)PYRIDO(1,2-D)PYRAZINE-8-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-2,3,5,7,11,11A-HEXAHYDRO-6-HYDROXY-3-METHYL-5,7-DIOXO-, (3S,11AR)- S-265744 |
| CAS登记号 | 1051375-10-0 |
| 物质唯一标识(Unique Ingredient Identifier) | HMH0132Z1Q |
| 分子式 | C19H17F2N3O5 |
| 国际化合物标识(International Chemical Identifier,InChI) | WCWSTNLSLKSJPK-LKFCYVNXSA-N |
| SMILES | [C@]12(Cn3c(C(N1[C@H](CO2)C)=O)c(c(c(c3)C(=O)NCc4c(cc(cc4)F)F)=O)O)[H] |
| 分子结构式 |  |
| 欧洲化学品管理局注册号(ECHA) | |
| 成分类型 | INGREDIENT SUBSTANCE / chemical |
| 关联数据 |
|
| 扩展资源 |